Zydus' biopharma arm acquires global proprietary rights for

India Business News: Sentynl, under Zydus Lifesciences, acquired global rights for Zokinvy, the first FDA-approved Progeria treatment. An acquisition milestone in expandin

Related Keywords

Ahmedabad , Gujarat , India , United Kingdom , Great Britain , Progeroid Laminopathies , Audrey Gordon , Zydus Lifesciences , Sentynl Therapeutics Inc , Progeria Research Foundation , European Union , Ahmedabad Headquartered Zydus Lifesciences , Hutchinson Gilford Progeria Syndrome , Processing Deficient Progeroid Laminopathies , Matt Heck , Executive Director , Business News , Zydus , Zokinvy , Rare Diseases , Progeria Treatment ,